2024/03/28 19:30:20 | |
---|---|
Price | |
0.7108 EUR | |
Difference | -1.85% (-0.01) |
ISIN | HK1093012172 |
Symbol | 1093 |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,614 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.7154 EUR |
High | 0.7154 EUR |
Low | 0.705 EUR |
Close (prev. day) | 0.7242 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 19:30:20 | |
---|---|
Price | |
0.7108 EUR | |
Difference | -1.85% (-0.01) |
ISIN | HK1093012172 |
Symbol | 1093 |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,614 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.7154 EUR |
High | 0.7154 EUR |
Low | 0.705 EUR |
Close (prev. day) | 0.7242 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +6.12% | -18.99% | -27.44% |
Perf (abs.) | +0.04 | -0.17 | -0.27 |
Beta | 0.78 | 0.70 | 0.35 |
Volatility | 39.40 | 35.93 | 42.05 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.7294 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.7159 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.7406 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.7459 EUR (1) |
YTD High | date | 0.8158 EUR (2024/01/04) |
YTD Low | date | 0.6384 EUR (2024/01/22) |
52 Weeks High | date | 0.9210 EUR (2023/04/17) |
52 Weeks Low | date | 0.6200 EUR (2023/10/05) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/03/28 | 22:26 | 0.7286 EUR | 0.00 | 4 |
Stuttgart | 2024/03/28 | 10:34 | 0.711 EUR | 0.00 | 4 |
Munich | 2024/03/28 | 08:16 | 0.7494 EUR | 0.00 | 2 |
Hong Kong Stock Exchange | 2024/03/28 | 09:08 | 6.15 HKD | - | - |
Hanover | 2024/03/28 | 08:10 | 0.7178 EUR | 0.00 | 1 |
Frankfurt | 2024/03/28 | 08:05 | 0.7176 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/02/28 | 21:36 | 0.805 USD | 0.09 | 1 |
Duesseldorf | 2024/03/28 | 19:30 | 0.7108 EUR | 0.00 | 7 |
Berlin | 2024/03/28 | 08:16 | 0.7176 EUR | 0.00 | 2 |
CSPC PHARMACEUTICAL GROUP LTD. |
- - |
No. 226 Huanghe Street - 050035 Shijiazhuang |
Telefon: +86-311-8703-7015 |
Fax: +86-311-8703-9608 |
E-mail: info@cpg.hk |
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Shijiazhuang, China. |
CAI Dongchen | Chairman of Managing Board |
CHAK Kin Man | Member of Executive Committee |
JIANG Hao | Member of Executive Committee |
LI Chunlei | Member of Executive Committee |
PAN Weidong | Member of Executive Committee |
WANG Huaiyu | Member of Executive Committee |
WANG Qingxi | Member of Executive Committee |
WANG Zhenguo | Member of Executive Committee |
ZHANG Cuilong | Member of Executive Committee |
Dong Chen Cai | Chairman of Supervisory Board |
Hao Jiang | Member of Supervisory Board |
Hong Guang Wang | Member of Supervisory Board |
Qingxi Wang | Member of Supervisory Board |
Bo Wang | Member of Supervisory Board |
Cheuk Kin Law | Member of Supervisory Board |
Chuan Chen | Member of Supervisory Board |
Chun Kwok Au | Member of Supervisory Board |
Chun Lei Li | Member of Supervisory Board |
Huai Yu Wang | Member of Supervisory Board |
Kin Man Chak | Member of Supervisory Board |
Quan Li | Member of Supervisory Board |
Wei Dong Pan | Member of Supervisory Board |
Zhen Guo Wang | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer